Dong-A ST donates medicines to Cambodian hospital

Detailed summary

South Korean pharmaceutical company Dong-A ST has donated 150 million won ($112,000) worth of prescription medicines to Hebron Medical Center in Cambodia as part of its ongoing…

South Korean pharmaceutical company Dong-A ST has donated 150 million won ($112,000) worth of prescription medicines to Hebron Medical Center in Cambodia as part of its ongoing efforts to improve healthcare access for underserved communities.

The company said Wednesday that it delivered the medicines to the hospital in Phnom Penh on Nov. 10, continuing a donation program that began in 2018.

Dong-A ST also signed a five-year agreement last year to provide medical support using HiCardi, a wearable patient monitoring device that continuously measures electrocardiogram readings and other vital signs.

In the second year of the program, the company provided local medical staff with training on installing and operating the devices.

Hebron Medical Center began as a free clinic established in 2007 by the late Dr. Kim Woo-jung. It has since developed into a nonprofit hospital treating 90,000 low-income patients annually.

“We hope this donation will help improve treatment and healthcare conditions for patients in Cambodia,” said Dong-A ST President and Chief Executive Officer Jung Jae-hun.

“We will continue expanding healthcare access in developing countries through medicines and digital healthcare solutions while fulfilling our social responsibilities as a global healthcare company.”

Dong-A ST has also supported healthcare institutions elsewhere in the developing world, including a 2023 donation of HiCardi devices to an MCM medical institution in Ethiopia.

Opening of the article, excerpted from Pulse (Maeil Business). To read the rest, open the article on the publisher's site.